Table 1.
Comparison of quantitative parameters in different PCa risk groups
| Low-risk | Intermediate-risk | High-risk | P value | ||
|---|---|---|---|---|---|
|
|
|
|
|||
| No. of patients | 14 | 20 | 50 | ||
| Inner gland | IMAX (%) | 234.1 ± 45.9 | 241.7 ± 41.8 | 244.3 ± 83.3 | 0.893 |
| RT (s) | 12.5 ± 4.7 | 12.5 ± 4.8 | 11.9 ± 4.4 | 0.897 | |
| TTP (s) | 18.9 ± 9.4 | 17.0 ± 9.7 | 16.3 ± 8.6 | 0.637 | |
| mTT (s) | 37.2 ± 12.7 | 36.2 ± 14.6 | 35.5 ± 18.7 | 0.944 | |
| Outer gland | IMAX (%) | 132.3 ± 66.0 | 110.7 ± 40.7 | 125.2 ± 45.4 | 0.390 |
| RT (s) | 15.5 ± 3.7 | 11.9 ± 3.0 | 12.8 ± 3.9 | 0.020 | |
| TTP (s) | 21.0 ± 7.5 | 16.6 ± 6.0 | 16.7 ± 6.1 | 0.074 | |
| mTT (s) | 36.3 ± 7.1 | 30.7 ± 7.3 | 30.3 ± 7.6 | 0.030 |